With a research background in cardiovascular pathophysiology and electrophysiology, Dr. Richard Kondo has published 12 peer-reviewed academic publications on the mechanisms of cardiac ischemia and arrhythmias. He is currently Director of Business Development at AnaBios, where he cultivates relationships with pharma and biotech companies that partner with AnaBios to assess compounds in the areas of pain, neuroscience, respiratory disease, heart failure and cardiac safety. Prior to joining AnaBios, Dr. Kondo was North American sales manager for Sophion Biosciences, managing sales for automated patch clamp technology for ion channel drug discovery. He received his PhD in Cellular Biophysics from Boston University.